113 related articles for article (PubMed ID: 38912999)
1. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
Evin C; Quéro L; Le Malicot K; Blanchet-Deverly S; Evesque L; Buchalet C; Lemanski C; Hamed NB; Rivin Del Campo E; Bauwens L; Pommier P; Lièvre A; Gouriou C; Tougeron D; Macé V; Sergent G; Diaz O; Zucman D; Mornex F; Locher C; De la Rochefordière A; Vendrely V; Huguet F
Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38912999
[TBL] [Abstract][Full Text] [Related]
2. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Gouriou C; Lemanski C; Pommier P; Le Malicot K; Saint A; Rivin Del Campo E; Evin C; Quero L; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; de la Rocherfordiere A; Drouet F; Vendrely V; Lièvre A
Br J Cancer; 2024 Mar; 130(5):769-776. PubMed ID: 38184691
[TBL] [Abstract][Full Text] [Related]
3. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
Bacci M; Quero L; Barbier E; Parrot L; Juguet F; Pommier P; Bazire L; Etienney I; Baba-Hamed N; Spindler L; François E; Ronchin P; Campo ERD; Lemanski C; Lièvre A; Siproudhis L; Abramowitz L; Lepage C; Vendrely V
Dig Liver Dis; 2021 Jun; 53(6):776-784. PubMed ID: 33867291
[TBL] [Abstract][Full Text] [Related]
4. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Vendrely V; Lemanski C; Pommier P; LE Malicot K; Saint A; Rivin Del Campo E; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; Minsat M; Drouet F; Larrouy A; Peiffert D; Lievre A; Zasadny X; Hautefeuille V; Mornex F; Lepage C; Quero L;
Radiother Oncol; 2023 Jun; 183():109542. PubMed ID: 36813175
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.
Leiker AJ; Wang CJ; Sanford NN; Aguilera TA; Karri S; Beg MS; Kazmi SA; Olson C; Matthews JA; Abdelnaby A; Meyer JJ; Folkert MR
Am J Clin Oncol; 2020 Oct; 43(10):701-708. PubMed ID: 32694298
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience.
Jethwa KR; Day CN; Sandhyavenu H; Gonuguntla K; Harmsen WS; Breen WG; Routman DM; Garda AE; Hubbard JM; Halfdanarson TR; Neben-Wittich MA; Merrell KW; Hallemeier CL; Haddock MG
Clin Transl Radiat Oncol; 2021 May; 28():17-23. PubMed ID: 33732911
[TBL] [Abstract][Full Text] [Related]
8. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution.
Holliday EB; Morris VK; Johnson B; Eng C; Ludmir EB; Das P; Minsky BD; Taniguchi C; Smith GL; Koay EJ; Koong AC; Delclos ME; Skibber JM; Rodriguez-Bigas MA; You YN; Bednarski BK; Tillman MM; Chang GJ; Jennings K; Messick CA
Oncologist; 2022 Feb; 27(1):40-47. PubMed ID: 35305097
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005).
Gul SK; Tepetam H; Yildiz F; Er I; Oksuz DC; Parvizi M; Ozden AS; Alicikus ZA; Sari SY; Alomari O; Gorken IB
Clin Colorectal Cancer; 2023 Sep; 22(3):318-326. PubMed ID: 37336706
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience.
Hammad N; Heilbrun LK; Gupta S; Tageja N; Philip PA; Shields AF; Smith D; El-Rayes BF
Am J Clin Oncol; 2011 Apr; 34(2):135-9. PubMed ID: 20523206
[TBL] [Abstract][Full Text] [Related]
12. Patient Outcomes With Dose Escalation Using Modern Radiotherapy Techniques: A Retrospective Review of Anal Cancer Treated at a Large Academic Institution Between 2010 and 2016.
Murchison SC; DeVries KJ; Atrchian S
Cureus; 2020 Oct; 12(10):e10989. PubMed ID: 33209545
[TBL] [Abstract][Full Text] [Related]
13. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
14. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of definitive radiation with volumetric modulated arc therapy and concurrent chemotherapy for squamous cell carcinoma of the anus in a regional Australian cancer centre.
Hsieh MT; Shakespeare TP; Winkley L; Goonetilleke D; Yap SZL; Tahir ARM
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):325-332. PubMed ID: 38450897
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.
Ghareeb A; Paramasevon K; Mokool P; van der Voet H; Jha M
Ann R Coll Surg Engl; 2019 Mar; 101(3):168-175. PubMed ID: 30482037
[TBL] [Abstract][Full Text] [Related]
17. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
[TBL] [Abstract][Full Text] [Related]
20. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.
Untiedt S; Rolf D; Scobioala S; Wolters H; Elsayad K; Oertel M; Kittel C; Pascher A; Rijcken E; Ullerich H; Glasbrenner B; Eich HT
Strahlenther Onkol; 2023 Aug; 199(8):749-760. PubMed ID: 36862155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]